-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Xponential Fitness, Lowers Price Target to $12

Benzinga·11/10/2025 14:44:10
Listen to the news
Guggenheim analyst John Heinbockel maintains Xponential Fitness (NYSE:XPOF) with a Buy and lowers the price target from $13 to $12.